| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-15 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |